
    
      To evaluate the safety and efficacy of Transfemoral Transcatheter Aortic Valve Implantation
      using SYM-SV-002 Aortic Bioprosthesis and SYM-DS-002 Transfemoral Delivery System in patients
      presenting with symptomatic severe aortic stenosis and with difficulty to safely undergo
      conventional surgical aortic valve replacement (AVR)
    
  